Eric Smith is an Oncology physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 262 publications with 7,075 citations (h-index 41); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
- The "AIM Study": Investigating Whether Actigraphy and Ideation Measures Can Promote Patient Safety
Sponsor: VA Office of Research and Development
- Prospective Functional Outcome Study of the Knee
Sponsor: Tufts Medical Center
- LFIT™ Anatomic CoCr Femoral Heads With X3® Polyethylene Insert Study
Sponsor: Stryker Orthopaedics
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Celgene CorporationProgram year20252 payments
- E.R. Squibb & Sons, L.L.C.Program year20241 payment
- Janssen Biotech, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2020)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
38.6%Thalidomide Analog38.6%Revlimid100%Part D<11 patientsDermatology
37.6%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor37.6%Acyclovir100%Part D<11 patientsMetabolism & gastrointestinal
23.8%Proton pump inhibitor23.8%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
11 NIH research awards on record, funded 2003–2026 per NIH RePORTER. The latest:
- Harnessing naturally occurring cell type-specific regulatory elements and normal HSC hematopoiesis to develop cell lineage-controlled CAR expression and continuously renewing CAR NK cells
Dana-Farber Cancer Inst
FY2026$1,541,577R01CA293092 - From biology to therapy: mechanism-informed targeting in translocation renal cell carcinoma
Dana-Farber Cancer Inst
FY2026$737,086R01CA302918 - Identifying Safe Stimulant Prescribing Practices to Protect Patients, Inform Key Program Initiatives, and Assist Providers
Edith Nourse Rogers Memorial Veterans Hospital
FY2026I01HX003453
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Mechanisms of Resistance and Treatment of Relapse after CAR T-cell Therapy for Large B-cell Lymphoma and Multiple Myeloma
Biology of Blood and Marrow Transplantation
2023 - Optimizing the manufacturing and antitumour response of CAR T therapy
Nature Reviews Bioengineering
2023 - Immunophenotypic correlates of sustained MRD negativity in patients with multiple myeloma
Nature Communications
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
Marc Sabatine, MD
Brigham and Women's Hospital
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”